Recent advancements in tuberculosis (TB) treatment regimens

Recent advancements in tuberculosis (TB) treatment regimens

Tuberculosis (TB) remains a global health challenge, with an estimated 10.6 million new cases and 1.3 million deaths in 2022. Recent years have seen a 3.9% increase in TB incidence, reversing prior declines. Drug-resistant TB poses significant hurdles, with multidrug-resistant (MDR) and rifampicin-r...

Full description

Saved in:
Bibliographic Details
Main Authors: Shyamala Ravikoti, Vikas Bhatia, Saykkulandai Kuppuswamy Mohanasundari
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-02-01
Series:Journal of Family Medicine and Primary Care
Subjects:
antitubercular agent
bedaquiline
linezolid and moxifloxacin
multidrug-resistant
pretomanid
tuberculosis
Online Access:https://journals.lww.com/10.4103/jfmpc.jfmpc_1237_24
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items